Ethyl 1-Cbz-5-Hydroxypiperidine-3-carboxylate is primarily used in organic synthesis as a key intermediate in the production of pharmaceuticals and bioactive compounds. Its structure, featuring both a Cbz-protected amine and a hydroxyl group, makes it valuable for constructing complex molecules, particularly in the development of piperidine-based drugs. The compound is often utilized in the synthesis of potential therapeutic agents targeting neurological disorders, as piperidine derivatives are known to interact with central nervous system receptors. Additionally, it serves as a building block in the preparation of peptidomimetics, which mimic peptide structures and are used in drug discovery to enhance stability and bioavailability. The Cbz protecting group can be selectively removed under mild conditions, allowing for further functionalization of the molecule. This versatility makes it a crucial component in medicinal chemistry research and the development of novel drug candidates.